Author: Piers Townley

Our Head of Research, Phil Hexley, outlines what happened at SNO: the 22nd Annual Meeting and Education Day of the Society for Neuro-Oncology

Researchers at UC San Francisco develop a vaccine to treat diffuse midline glioma by using the patient’s immune system to attack the tumour cells

Our Head of Research, Phil Hexley, outlines what happened at SNO: the 22nd Annual Meeting and Education Day of the Society for Neuro-Oncology

Yesterday, along with partners of the Less Survivable Cancers Taskforce, we met with Government Minister Steve Brine, Parliamentary Under-Secretary (Department of Health)

The Neuro-Oncology team at King’s College Hospital are excited to welcome Charlotte Robinson into the first low grade glioma CNS post in the UK

PAC-1, an anti-cancer drug is approved for phase 1(b) clinical trials in humans by the US Food and Drug Administration

On Thursday Alexander Stewart MSP led a debate in the Scottish Parliament on Brain Tumour Awareness in Scotland, as several MSPs expressed their support for action to raise greater awareness of the disease

Our Policy & Public Affairs Manager Cameron Miller, outlines tomorrow’s MSP debate in the Scottish Parliament

In the UK, 11,000 people are diagnosed with a brain tumour every year. This figure simply has to change

The multi-award winning HeadSmart campaign has gained international recognition after being recommended to the Australian Government as a “model to inform the public about low survival rate cancers and their symptoms”

This week our Chief Scientific Officer, Dr David Jenkinson, is speaking at a meeting of the All Party Parliamentary Group on brain tumours about what risks Brexit poses

Researchers in collaboration with ZIOPHARM Oncology, a biopharmaceutical company announce positive updates on a Phase 1 clinical trials testing a new therapy

Inspired by our Community Fundraiser Shona Richardson’s personal story, Alexander Stewart MSP has tabled a debate in the Scottish Parliament on 7 December

The resources have been developed in response to a nationwide gap in information. They will improve the quality of life for those affected

Are they good for raising awareness or should the bubble burst? Our senior media & PR Officer Carol Dyce examines

Ally is an academic psychiatry trainee, nearly a Consultant psychiatrist, currently funded by The Charity to study non-drug treatments for fatigue in people living with a brain tumour

Lewis and his team headwest to raise £75,000 to help fund HeadSmart

Researchers at Glasgow University have discovered that ovarian cancer drug, olaparib, has the potential to treat patients with glioblastomas

Gideon Burrows has written his second book with personal stories, experiences, statistics and information, helped by a huge amount of people directly affected

A gene therapy to treat recurrent high-grade gliomas is accelerated to Phase 3 clinical trials, after the success of Phase 1 clinical trials by the US Food and Drug Administration (FDA)

Our Policy & Public Affairs Manager, Cameron Miller, on Australia’s Cure Brain Cancer AU$100m investment fund

A team of researchers at UCLA have discovered a combination of drugs to prevent the growth of glioblastomas, as well as kill tumour cells in mice with glioblastomas

Jonathan Canty, our Project Information Analyst, reflects on the SNP Conference in Glasgow last week

A research team at the University of Texas, led by Professor George Biros have been able to accurately characterise gliomas using a super computer